Telemedicine provider Teladoc Health signs a $18.5B deal to buy Livongo, maker of connected devices for managing diabetes and other chronic conditions
In a sign of the growing importance and value of digital healthcare in the world of medicine, two of the industry's publicly traded companies …
Sources: telemedicine company Amwell, formerly American Well, confidentially files for IPO after it raised $194M in May; will seek September offering
Amwell IPO after a $194M private raise and following Livongo, One Medical, and Teladoc raising a combined $1.6 billion in convertible notes in the last month. https://twitter.com/...
Livongo, which makes a platform to help people manage chronic conditions, raises $350M+ in its IPO, closing up 36% at $38.10 and valued at ~$3.6B
Christina Farr / CNBC :
Livongo, which sells connected devices to monitor diabetes, files for an IPO, says it had $32.06M in revenue in Q1 2019 with a net loss of $14.96M
KEY POINTS — The company provide tools for people with chronic disease, and works with some 600 employers and health plans.
Livongo, which helps patients manage diabetes and hypertension via connected devices and a cloud based platform, raises $105M Series E at $800M+ valuation
Livongo Health, a startup that develops connected devices and software for patients with diabetes and other chronic conditions …